Bosulif 100 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DR26F9BL3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,023
Award facts
- Contract value 100% obligated
- $12,023.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,023.24 to AmerisourceBergen Drug Corp for the supply of Bosulif 100 mg tablets (120-count units) on November 13, 2025, with an ultimate completion date of December 5, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
The pharmaceutical supply falls under AmerisourceBergen's comprehensive global pharmaceutical support vehicle, which enables the company to deliver a broad range of medications and medical supplies to support military healthcare programs worldwide. Bosulif is a specialized oncology medication, reflecting AmerisourceBergen's role as a critical vendor for federal medical procurement across multiple therapeutic domains. The company serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its DLA contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies. This delivery order exemplifies the operational execution of AmerisourceBergen's larger pharmaceutical prime vendor arrangement with the federal government.
Quick answers
Who was awarded contract SPE2DR26F9BL3?
SPE2DR26F9BL3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F9BL3 worth?
The government has obligated $12,023 on SPE2DR26F9BL3.
Is contract SPE2DR26F9BL3 an order under another contract?
Yes. SPE2DR26F9BL3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BL3 competed?
The extent of competition for SPE2DR26F9BL3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award